Page last updated: 2024-10-23

biperiden and Paralysis

biperiden has been researched along with Paralysis in 2 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JAHN, G1
SCHMUCKER, E1

Other Studies

2 other studies available for biperiden and Paralysis

ArticleYear
[Medical treatment of spastic paralysis; experience with akineton].
    Die Medizinische, 1958, Mar-22, Volume: 12, Issue:12

    Topics: Biperiden; Cardiovascular Agents; Muscle Relaxants, Central; Muscle Spasticity; Paraganglioma; Paral

1958
[On the treatment of spastic disorders with akineton].
    Therapie der Gegenwart, 1960, Volume: 99

    Topics: Biperiden; Humans; Muscle Spasticity; Paralysis; Piperidines

1960